Literature DB >> 7827477

Integrated multimodality monitoring in the neurosurgical intensive care unit.

J D Miller1, I R Piper, P A Jones.   

Abstract

The selection of variables for continuous monitoring in the neurosurgical intensive care unit is based upon the requirement for constant perfusion and oxygenation of the brain and knowledge of the frequency and prognostic significance of abnormal values. Both arterial and intracranial pressure must be considered in the form of cerebral perfusion pressure. Body temperature and arterial oxygen saturation are essential to monitoring. Measurement of jugular venous oxygen saturation and cerebral blood flow velocity provide information of value in determining the source of raised intracranial pressure, the most appropriate means of treating it, and the safety of therapy.

Entities:  

Mesh:

Year:  1994        PMID: 7827477

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  4 in total

1.  Clinical evaluation of extracellular amino acids in severe head trauma by intracerebral in vivo microdialysis.

Authors:  I R Whittle; I R Piper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

Review 2.  Imaging Guidance for Therapeutic Delivery: The Dawn of Neuroenergetics.

Authors:  Vilakshan Alambyan; Jonathan Pace; Persen Sukpornchairak; Xin Yu; Hamza Alnimir; Ryan Tatton; Gautham Chitturu; Anisha Yarlagadda; Ciro Ramos-Estebanez
Journal:  Neurotherapeutics       Date:  2020-04       Impact factor: 7.620

3.  Dynamic monitors of brain function: a new target in neurointensive care unit.

Authors:  Enrico Bosco; Elisabetta Marton; Alberto Feletti; Bruno Scarpa; Pierluigi Longatti; Paolo Zanatta; Emanuele Giorgi; Carlo Sorbara
Journal:  Crit Care       Date:  2011-07-15       Impact factor: 9.097

4.  Nao-Xue-Shu Oral Liquid Protects and Improves Secondary Brain Insults of Hypertensive Cerebral Hemorrhage.

Authors:  Hongning Jiang; Ying Qin; Te Liu; Liang Zhang; Mingzhe Wang; Baofeng Qin; Wenfei Jiang; Weilong Liao; Weidong Pan
Journal:  Evid Based Complement Alternat Med       Date:  2016-03-27       Impact factor: 2.629

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.